Expect a Serum Creatinine Bump When Starting an ACEI or ARB in Kidney Disease
June 2014
Questions often come up about how to safely use ACEIs or ARBs in patients with chronic kidney disease.
We know these meds slow the progression of kidney disease.
But blocking angiotensin can reduce kidney filtration...and sometimes lead to a bump in serum creatinine (SCr) and potassium.
Upgrade now for access to this resource
This content is not available under the subscriptions purchased by your organization, but you can add it on!
Prescriber Insights: APRN includes
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations